July 2, 2020 08:48 AM EDT

Novavax snags Ben Machielse for CMC and promotes a trio of staffers; Marty Duvall lands another CEO post at Oncopeptides

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Novavax has been making waves recently by securing a $384 million commitment from CEPI to cover R&D and manufacturing for its Covid-19 vaccine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Novavax snags Ben Machielse for CMC and promotes a trio of staffers; Marty Duvall lands another CEO post at Oncopeptides

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Sign up to read this article for free.

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

CBER's deputy director departs as staff shakeup continues

FDA says Ozempic, Wegovy shortage is over

Will CRISPR matter?

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

No­vavax snags Ben Machielse for CMC and pro­motes a trio of staffers; Mar­ty Du­vall lands an­oth­er CEO post at On­copep­tides

Copy Chief

Editor

Sign up to read this article for free.

Novavax snags Ben Machielse for CMC and promotes a trio of staffers; Marty Duvall lands another CEO post at Oncopeptides